These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6192292)

  • 1. Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis.
    Fasske E; Morgenroth K
    Lung; 1983; 161(3):133-46. PubMed ID: 6192292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surfactant-inducted suppressive action on fibroblasts of pulmonary macrophages from rats with fibrosis after intratracheal administration of bleomycin].
    Taganovich AD
    Probl Tuberk; 1991; (12):46-9. PubMed ID: 1725060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model].
    Hu P; Gao ZC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Aug; 18(8):474-8. PubMed ID: 16887059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung.
    Daly HE; Baecher-Allan CM; Barth RK; D'Angio CT; Finkelstein JN
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):303-10. PubMed ID: 9070353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The morphofunctional changes in the alveolar epithelium, macrophages and pulmonary surfactant of rats with bleomycin-induced fibrosis].
    Sluka BA; Taganovich AD
    Morfologiia; 1993; 104(3-4):119-31. PubMed ID: 7534175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration].
    Ekimoto H; Takahashi K; Matsuda A; Umezawa H
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2550-7. PubMed ID: 6197032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis.
    Schmidt R; Ruppert C; Markart P; Lübke N; Ermert L; Weissmann N; Breithecker A; Ermert M; Seeger W; Günther A
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):218-31. PubMed ID: 14998687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
    Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
    J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
    Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
    Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of bleomycin-induced pulmonary fibrosis.
    Walters DM; Kleeberger SR
    Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.46. PubMed ID: 22294226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
    He F; Zhou A; Feng S
    PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 promotes pulmonary fibrosis when administered during the remodelling phase following a bleomycin-induced lung injury.
    Gendron DR; Lemay AM; Lecours PB; Perreault-Vallières V; Huppé CA; Bossé Y; Blanchet MR; Dion G; Marsolais D
    Pulm Pharmacol Ther; 2017 Jun; 44():50-56. PubMed ID: 28323056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats.
    Cross CE; Warren D; Gerriets JE; Wilson DW; Halliwell B; Last JA
    J Lab Clin Med; 1985 Oct; 106(4):433-8. PubMed ID: 2413151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis.
    Lucey EC; Ngo HQ; Agarwal A; Smith BD; Snider GL; Goldstein RH
    Lab Invest; 1996 Jan; 74(1):12-20. PubMed ID: 8569173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
    J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of alveolar macrophages by BCG vaccine enhances the process of lung fibrosis induced by bleomycin.
    Chyczewska E; Chyczewski L; Bańkowski E; Sułkowski S; Nikliński J
    Folia Histochem Cytobiol; 1993; 31(3):113-6. PubMed ID: 7505240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine mapping of the major bleomycin-induced pulmonary fibrosis susceptibility locus in mice.
    Bergeron ME; Stefanov A; Haston CK
    Mamm Genome; 2018 Oct; 29(9-10):670-679. PubMed ID: 30173367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis.
    Belperio JA; Dy M; Murray L; Burdick MD; Xue YY; Strieter RM; Keane MP
    J Immunol; 2004 Oct; 173(7):4692-8. PubMed ID: 15383605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of an additional fibrotic response caused by oxygen in the lungs of rats after the intratracheal administration of bleomycin.
    Veninga TS; Vriesendorp R; Blom-Muilwijk MC; Sleyfer DT; Konings AW
    Br J Anaesth; 1988 Oct; 61(4):413-8. PubMed ID: 2461215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice.
    Tokuda A; Itakura M; Onai N; Kimura H; Kuriyama T; Matsushima K
    J Immunol; 2000 Mar; 164(5):2745-51. PubMed ID: 10679116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.